Cargando…

Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’

Detalles Bibliográficos
Autores principales: Fazio, Nicola, Spada, Francesca, Gervaso, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380486/
https://www.ncbi.nlm.nih.gov/pubmed/34507830
http://dx.doi.org/10.1016/j.ejca.2021.08.021
_version_ 1783741206482649088
author Fazio, Nicola
Spada, Francesca
Gervaso, Lorenzo
author_facet Fazio, Nicola
Spada, Francesca
Gervaso, Lorenzo
author_sort Fazio, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-8380486
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83804862021-08-23 Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’ Fazio, Nicola Spada, Francesca Gervaso, Lorenzo Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-11 2021-08-23 /pmc/articles/PMC8380486/ /pubmed/34507830 http://dx.doi.org/10.1016/j.ejca.2021.08.021 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Fazio, Nicola
Spada, Francesca
Gervaso, Lorenzo
Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title_full Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title_fullStr Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title_full_unstemmed Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title_short Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
title_sort reply to comments on ‘covid-19 in patients with neuroendocrine neoplasms: preliminary results of a worldwide survey (the intensive study)’
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380486/
https://www.ncbi.nlm.nih.gov/pubmed/34507830
http://dx.doi.org/10.1016/j.ejca.2021.08.021
work_keys_str_mv AT fazionicola replytocommentsoncovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT spadafrancesca replytocommentsoncovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT gervasolorenzo replytocommentsoncovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy